Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
7.66
-0.14 (-1.79%)
Feb 27, 2026, 4:00 PM EST - Market closed
Intensity Therapeutics Employees
As of December 31, 2024, Intensity Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,676,571
Market Cap
19.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | 0 | - |
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| VYNE Therapeutics | 13 |
| Serina Therapeutics | 13 |
| FibroBiologics | 13 |
| NanoViricides | 7 |
| Lexaria Bioscience | 7 |
| Cadrenal Therapeutics | 4 |
| Jupiter Neurosciences | 4 |
INTS News
- 15 days ago - Intensity Therapeutics Announces Reverse Stock Split - PRNewsWire
- 6 weeks ago - Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - PRNewsWire
- 2 months ago - Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PRNewsWire
- 3 months ago - Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - PRNewsWire
- 3 months ago - Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - PRNewsWire
- 4 months ago - Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Intensity Therapeutics, Inc. (INTS) Discusses eBioMedicine Paper Study Results and Underlying Technology Transcript - Seeking Alpha
- 4 months ago - Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PRNewsWire